INO-3107 With Electroporation (EP) in Participants With HPV-6- and/or HPV-11-Associated Recurrent Respiratory Papillomatosis (RRP)

NCT04398433 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Papillomatosis

Interventions

DRUG: INO-3107
DEVICE: CELLECTRA® 2000

Sponsor

Inovio Pharmaceuticals